REGN Forecast



Bearish<—>Bullish



80% Confidence




Bullish Case: Regeneron's robust pipeline and strong product demand, coupled with potential FDA approvals, provide growth momentum despite competitive pressures.




Bearish Case: Regeneron's high implied volatility and market skepticism, exacerbated by regulatory hurdles and competitive challenges, create downside risk.




Potential Outcomes:

1. FDA approvals drive growth (60%).

2. Regulatory setbacks lead to underperformance (30%).

3. Stability amid volatility persists (10%).



May 15, 2025


Regeneron Pharmaceuticals Forecast

REGN        Regeneron Pharmaceuticals











Correlated Assets

Assets that tend to move strongly with REGN










Become a more profitable investor with AI optimized trading strategies






×

Chat with REGN


 Ask any question about REGN!